Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition

The high incidence of colonization of the cystic fibrosis (CF) airway with Pseudomonas aeruginosa has been attributed to several mechanisms including increased numbers of asialoglycolipid receptors, which may be further increased by exposure to the bacterial exoproduct, neuraminidase. This study examined whether the adherence of P. aeruginosa to fresh CF respiratory epithelial cells can be reduced in vitro by anti-asialoGM1 (anti-aGM1) antibody, neuraminidase inhibition, or the use of asialoGM1 tetrasaccharide as a competitive inhibitor. CF nasal epithelial cells were incubated with a nonmucoid strain of P. aeruginosa, in the presence or absence of a polyclonal anti-aGM1 antibody, the neuraminidase inhibitor 2,3-dehydro-2-deoxy-N-acetyl-neuraminic acid (DANA), or the tetrasaccharide moiety of aGM1. Adherence of bacteria to the apical surface of ciliated epithelial cells was quantified using scanning electron microscopy. Incubation of the cells with bacteria in the presence of either anti-aGM1 antibody or DANA significantly reduced bacterial adherence by 51(7)%, (p<0.01), and 34(9)%, (p<0.01), respectively. In contrast, no significant effect on P. aeruginosa binding was seen in the presence of aGM1 tetrasaccharide. The data are consistent with previous studies on cultured cells, and suggest that the in vivo effects of such interventions should be explored as potential mechanisms to reduce Pseudomonas aeruginosa colonization in cystic fibrosis.

This article has been cited by other articles:

				A. Emam, A. R. Yu, H.-J. Park, R. Mahfoud, J. Kus, L. L. Burrows, and C. A. Lingwood Laboratory and clinical Pseudomonas aeruginosa strains do not bind glycosphingolipids in vitro or during type IV pili-mediated initial host cell attachment. Microbiology, September 1, 2006; 152(Pt 9): 2789 - 2799. [Abstract] [Full Text] [PDF]

				N. McNamara, M. Gallup, A. Sucher, I. Maltseva, D. McKemy, and C. Basbaum AsialoGM1 and TLR5 Cooperate in Flagellin-Induced Nucleotide Signaling to Activate Erk1/2 Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 653 - 660. [Abstract] [Full Text] [PDF]

				J. C. Hsieh, D. M. Tham, W. Feng, F. Huang, S. Embaie, K. Liu, D. Dean, R. Hertle, D. J. FitzGerald, and R. J. Mrsny Intranasal Immunization Strategy To Impede Pilin-Mediated Binding of Pseudomonas aeruginosa to Airway Epithelial Cells Infect. Immun., November 1, 2005; 73(11): 7705 - 7717. [Abstract] [Full Text] [PDF]

				R. D. Kensinger, B. J. Catalone, F. C. Krebs, B. Wigdahl, and C.-L. Schengrund Novel Polysulfated Galactose-Derivatized Dendrimers as Binding Antagonists of Human Immunodeficiency Virus Type 1 Infection Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1614 - 1623. [Abstract] [Full Text] [PDF]

				P. Lanotte, S. Watt, L. Mereghetti, N. Dartiguelongue, A. Rastegar-Lari, A. Goudeau, and R. Quentin Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins J. Med. Microbiol., January 1, 2004; 53(1): 73 - 81. [Abstract] [Full Text] [PDF]

				K. E. A. Darling and T. J. Evans Effects of Nitric Oxide on Pseudomonas aeruginosa Infection of Epithelial Cells from a Human Respiratory Cell Line Derived from a Patient with Cystic Fibrosis Infect. Immun., May 1, 2003; 71(5): 2341 - 2349. [Abstract] [Full Text] [PDF]

				T. H. Schroeder, T. Zaidi, and G. B. Pier Lack of Adherence of Clinical Isolates of Pseudomonas aeruginosa to Asialo-GM1 on Epithelial Cells Infect. Immun., February 1, 2001; 69(2): 719 - 729. [Abstract] [Full Text] [PDF]

				A. BUSH, H. TIDDENS, and M. SILVERMAN Clinical Implications of Inflammation in Young Children Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S11 - 14. [Full Text] [PDF]